Clarity Pharmaceuticals Ltd.ASX: CU6

Becoming a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX · · 6 pages · English

Release

Docusign Envelope ID: F516E6E4-0E6A-85FE-812F-698A1BB01E82 603 Page 1 of 3 15 July 2001 Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company Name/Scheme CLARITY PHARMACEUTICALS LTD ACN/ARSN 143 005 341 1. Details of substantial holder (1) Retail Employees...

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases